High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial
High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial
复制标题
丙泊酚镇静胃镜检查期间高流量鼻插管氧疗和缺氧:随机多中心临床试验
DOI:
10.1016/j.gie.2019.06.033
复制
发表时间:
2019-10-01
影响因子:
7.7
通讯作者:
Su, Diansan
中科院分区:
文献类型:
--
作者:
Lin, Yuxuan;Zhang, Xiaoqing;Su, Diansan
Background and Aims: Hypoxia is one of the most frequent adverse events with sedated GI endoscopy and can lead to serious consequences. No modalities have been found previously to prevent hypoxia. High-flow nasal cannula (HFNC) supportive oxygen therapy provides heated and humidified oxygen up to 60 L/minute. Because of its ability to improve respiratory function and good tolerance, we aimed to evaluate the validity and safety of HFNC supportive oxygen therapy in preventing the incidence of hypoxia in patients undergoing gastroscopy with propofol sedation.Methods: In a multicenter, prospective randomized single-blinded study, 1994 outpatients undergoing routine gastroscopy with propofol sedation provided by an anesthesiologist were randomized into 2 groups: the nasal cannula group (O-2 [2 L/minute] was supplied via an HFNC) and the HFNC group (O-2 [30-60 L/minute] was supplied via an HFNC) at 3 centers from November 2017 to February 2018. The primary outcome was the incidence of hypoxia. Other adverse events were also recorded.Results: HFNC supportive oxygen therapy decreased the incidence of hypoxia (75%